Does detectable hs-cTnT predict death and cardiovascular outcomes in patients with chest pain and stable troponin levels?
In patients presenting with chest pain and stable troponin levels, even minimally detectable hs-cTnT is a prognostic marker for increased mortality and cardiovascular risk.
Among patients with chest pain and stable troponin levels, any detectable level of hs-cTnT is associated with an increased risk of death and cardiovascular outcomes and should merit further attention.
Roos et al. (Sun,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: